ICUI 财务： ICU Medical Inc AI 分析

Q: ICU Medical Inc 的关键财务报表是什么？

根据最新的财务报表（Form-10K），ICU Medical Inc 的总资产为 $4,203，净损失为 $-117

Q: ICUI 的关键财务比率是什么？

ICU Medical Inc 的流动比率是 1.87，净利 margin 为 -4.91，每股销售为 $97.67。

Q: ICU Medical Inc 的收入按细分市场或地理位置如何划分？

ICU Medical Inc 最大收入来源是 Consumables，在最近的收益报告中收入为 1,038,869,000。就地区而言， United States 是 ICU Medical Inc 的主要市场，收入为 1,532,104,000。

Q: ICU Medical Inc 是否盈利？

不，根据最新的财务报表，ICU Medical Inc 的净损失为 $-117

Q: ICU Medical Inc 有负债吗？

是的，ICU Medical Inc 的负债为 2,238

Q: ICU Medical Inc 的流通股有多少？

ICU Medical Inc 的总流通股为 24.51

主页

股票

ICUI

ICUI 财务

ICU Medical Inc

$156.17

0.67%

$1.04

收盘价：Jan 16, 16:00:00 GMT-5

$156.17

盘后：Jan 16, 20:00:00 GMT-5

概述预测收益股息财务数据

收入

资产负债表

现金流量

年度

季度性

ICUI 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
营收	2,320	2,382	2,259	2,280	1,316	1,271
营收同比增长 (YoY)	-1%	5%	-1%	73%	4%	0%
营收成本	1,474	1,557	1,519	1,582	824	809
毛利润	846	824	739	697	491	461
销售、一般及管理费用	626	637	605	607	301	283
研发	88	88	85	93	47	42
营业费用	715	721	675	669	350	335
其他非经营性收入 (费用)	0	-1	0	-1	0	2
税前利润	28	-66	-78	-114	123	97
所得税费用	37	51	-48	-40	20	10
净利润	-7	-117	-29	-74	103	86
净利润增长	-94%	303%	-61%	-172%	20%	-15%
稀释后流通股数	24.68	24.38	24.09	23.9	21.8	21.6
股份同比变动 (YoY)	1%	1%	1%	10%	1%	0%
每股收益 (摊薄)	-0.31	-4.82	-1.23	-3.11	4.74	4.02
每股收益增长率	-93%	292%	-60%	-166%	18%	-14%
自由现金流	62	113	72	-161	186	122
每股自由现金流	--	--	--	--	--	--
毛利率	36.46%	34.59%	32.71%	30.57%	37.31%	36.27%
营业利润率	5.6%	4.28%	2.83%	1.22%	10.71%	9.83%
净利率	-0.3%	-4.91%	-1.28%	-3.24%	7.82%	6.76%
自由现金流利润率	2.67%	4.74%	3.18%	-7.06%	14.13%	9.59%
EBITDA	332	321	292	263	230	210
EBITDA 利润率	14.31%	13.47%	12.92%	11.53%	17.47%	16.52%
EBITDA 中的折旧与摊销	202	219	228	235	89	85
EBIT	130	102	64	28	141	125
EBIT 利润率	5.6%	4.28%	2.83%	1.22%	10.71%	9.83%
有效税率	132.14%	-77.27%	61.53%	35.08%	16.26%	10.3%

Follow-Up Questions

ICU Medical Inc 的关键财务报表是什么？



ICUI 的关键财务比率是什么？



ICU Medical Inc 的收入按细分市场或地理位置如何划分？



ICU Medical Inc 是否盈利？



ICU Medical Inc 有负债吗？



ICU Medical Inc 的流通股有多少？



关键数据

前收盘价

$155.12

开盘价

$154.47

当日区间

$154.34 - $157.48

52周范围

$107 - $175.51

交易量

310.5K

平均成交量

250.0K

每股收益（TTM）

-0.31

股息收益率

市值

$3.8B

什么是 ICUI？

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 15,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.

功能特性

交易策略